LYTIR

Insider · SEC Form 4 · 10% Owner

AH Bio Fund II, L.P.

In the 12 months to Nov 19, 2026, on the open market: bought $5.0M of SCTX. Filed 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. SCTXBought: Scribe Therapeutics, Inc. Jul 27, 2026 333,333 shares filed Jul 29, 2026 2,385,075 shares held indirectly after, as filed filing $5.0M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Stakes filed (13D/13G)

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G

  1. SCTXAH Bio Fund II, L.P. filed Nov 16, 2026 Schedule 13G passive issuer: Scribe Therapeutics Inc. filing 16.3%
  2. NAUTAH Bio Fund II, L.P. filed Sep 11, 2026 Schedule 13D/A may seek influence 6,263,235 shares issuer: Nautilus Biotechnology, Inc. filing 4.9%
  3. NAUTAH Bio Fund II, L.P. filed Aug 28, 2026 Schedule 13D/A may seek influence 7,684,932 shares issuer: Nautilus Biotechnology, Inc. filing 6%
  4. NAUTAH Bio Fund II, L.P. filed Jun 30, 2026 Schedule 13D/A may seek influence 8,366,966 shares issuer: Nautilus Biotechnology, Inc. filing 6.6%

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • SCTX: conversion (code C), 2 entries, Jul 27, 2026
Code C
A conversion of a derivative security, such as preferred stock or units, into shares.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.